Ann: Completion of patient dosing in maiden TRP-8803 trial, page-4

Looks good Mason but so far listening to the CEO presentations and watching him skip over most of the science slides, while exuding Malfoy vibes don’t give me confidence. Way of presenting comes across similar to the folk at pyramid scheme or the motivational speaker types in some of his other videos, nothing strikes me as a biotech 35yr career professional.

Interesting to see Peter Malloy as CBO & also top SH is William Garner. Already 1b SOI, will need further capital to progress and more dilution.

Some big names, a different way of using the drug than other companies. After having IHL take me to a nice green place on back of Covid as well as the Glit pump squad now back way back down even after the USA listing I hope this does well. I hold a tiny amount in the same views and hopes on the science, but do have some question marks on management to deliver but know BG doesn’t do things to lose money.